Cargando…

Neuroprotective Effect of Artichoke-Based Nanoformulation in Sporadic Alzheimer’s Disease Mouse Model: Focus on Antioxidant, Anti-Inflammatory, and Amyloidogenic Pathways

The vast socio-economic impact of Alzheimer’s disease (AD) has prompted the search for new neuroprotective agents with good tolerability and safety profile. With its outstanding role as antioxidant and anti-inflammatory, alongside its anti-acetylcholinesterase activity, the artichoke can be implemen...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Nashar, Heba A. S., Abbas, Haidy, Zewail, Mariam, Noureldin, Mohamed H., Ali, Mai M., Shamaa, Marium M., Khattab, Mohamed A., Ibrahim, Nehal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610800/
https://www.ncbi.nlm.nih.gov/pubmed/36297313
http://dx.doi.org/10.3390/ph15101202
_version_ 1784819367523909632
author El-Nashar, Heba A. S.
Abbas, Haidy
Zewail, Mariam
Noureldin, Mohamed H.
Ali, Mai M.
Shamaa, Marium M.
Khattab, Mohamed A.
Ibrahim, Nehal
author_facet El-Nashar, Heba A. S.
Abbas, Haidy
Zewail, Mariam
Noureldin, Mohamed H.
Ali, Mai M.
Shamaa, Marium M.
Khattab, Mohamed A.
Ibrahim, Nehal
author_sort El-Nashar, Heba A. S.
collection PubMed
description The vast socio-economic impact of Alzheimer’s disease (AD) has prompted the search for new neuroprotective agents with good tolerability and safety profile. With its outstanding role as antioxidant and anti-inflammatory, alongside its anti-acetylcholinesterase activity, the artichoke can be implemented in a multi-targeted approach in AD therapy. Moreover, artichoke agricultural wastes can represent according to the current United Nations Sustainable Development goals an opportunity to produce medicinally valuable phenolic-rich extracts. In this context, the UPLC-ESI-MS/MS phytochemical characterization of artichoke bracts extract revealed the presence of mono- and di-caffeoylquinic acids and apigenin, luteolin, and kaempferol O-glycosides with remarkable total phenolics and flavonoids contents. A broad antioxidant spectrum was established in vitro. Artichoke-loaded, chitosan-coated, solid lipid nanoparticles (SLNs) were prepared and characterized for their size, zeta potential, morphology, entrapment efficiency, release, and ex vivo permeation and showed suitable colloidal characteristics, a controlled release profile, and promising ex vivo permeation, indicating possibly better physicochemical and biopharmaceutical parameters than free artichoke extract. The anti-Alzheimer potential of the extract and prepared SLNs was assessed in vivo in streptozotocin-induced sporadic Alzheimer mice. A great improvement in cognitive functions and spatial memory recovery, in addition to a marked reduction of the inflammatory biomarker TNF-α, β-amyloid, and tau protein levels, were observed. Significant neuroprotective efficacy in dentate Gyrus sub-regions was achieved in mice treated with free artichoke extract and to a significantly higher extent with artichoke-loaded SLNs. The results clarify the strong potential of artichoke bracts extract as a botanical anti-AD drug and will contribute to altering the future medicinal outlook of artichoke bracts previously regarded as agro-industrial waste.
format Online
Article
Text
id pubmed-9610800
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96108002022-10-28 Neuroprotective Effect of Artichoke-Based Nanoformulation in Sporadic Alzheimer’s Disease Mouse Model: Focus on Antioxidant, Anti-Inflammatory, and Amyloidogenic Pathways El-Nashar, Heba A. S. Abbas, Haidy Zewail, Mariam Noureldin, Mohamed H. Ali, Mai M. Shamaa, Marium M. Khattab, Mohamed A. Ibrahim, Nehal Pharmaceuticals (Basel) Article The vast socio-economic impact of Alzheimer’s disease (AD) has prompted the search for new neuroprotective agents with good tolerability and safety profile. With its outstanding role as antioxidant and anti-inflammatory, alongside its anti-acetylcholinesterase activity, the artichoke can be implemented in a multi-targeted approach in AD therapy. Moreover, artichoke agricultural wastes can represent according to the current United Nations Sustainable Development goals an opportunity to produce medicinally valuable phenolic-rich extracts. In this context, the UPLC-ESI-MS/MS phytochemical characterization of artichoke bracts extract revealed the presence of mono- and di-caffeoylquinic acids and apigenin, luteolin, and kaempferol O-glycosides with remarkable total phenolics and flavonoids contents. A broad antioxidant spectrum was established in vitro. Artichoke-loaded, chitosan-coated, solid lipid nanoparticles (SLNs) were prepared and characterized for their size, zeta potential, morphology, entrapment efficiency, release, and ex vivo permeation and showed suitable colloidal characteristics, a controlled release profile, and promising ex vivo permeation, indicating possibly better physicochemical and biopharmaceutical parameters than free artichoke extract. The anti-Alzheimer potential of the extract and prepared SLNs was assessed in vivo in streptozotocin-induced sporadic Alzheimer mice. A great improvement in cognitive functions and spatial memory recovery, in addition to a marked reduction of the inflammatory biomarker TNF-α, β-amyloid, and tau protein levels, were observed. Significant neuroprotective efficacy in dentate Gyrus sub-regions was achieved in mice treated with free artichoke extract and to a significantly higher extent with artichoke-loaded SLNs. The results clarify the strong potential of artichoke bracts extract as a botanical anti-AD drug and will contribute to altering the future medicinal outlook of artichoke bracts previously regarded as agro-industrial waste. MDPI 2022-09-28 /pmc/articles/PMC9610800/ /pubmed/36297313 http://dx.doi.org/10.3390/ph15101202 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
El-Nashar, Heba A. S.
Abbas, Haidy
Zewail, Mariam
Noureldin, Mohamed H.
Ali, Mai M.
Shamaa, Marium M.
Khattab, Mohamed A.
Ibrahim, Nehal
Neuroprotective Effect of Artichoke-Based Nanoformulation in Sporadic Alzheimer’s Disease Mouse Model: Focus on Antioxidant, Anti-Inflammatory, and Amyloidogenic Pathways
title Neuroprotective Effect of Artichoke-Based Nanoformulation in Sporadic Alzheimer’s Disease Mouse Model: Focus on Antioxidant, Anti-Inflammatory, and Amyloidogenic Pathways
title_full Neuroprotective Effect of Artichoke-Based Nanoformulation in Sporadic Alzheimer’s Disease Mouse Model: Focus on Antioxidant, Anti-Inflammatory, and Amyloidogenic Pathways
title_fullStr Neuroprotective Effect of Artichoke-Based Nanoformulation in Sporadic Alzheimer’s Disease Mouse Model: Focus on Antioxidant, Anti-Inflammatory, and Amyloidogenic Pathways
title_full_unstemmed Neuroprotective Effect of Artichoke-Based Nanoformulation in Sporadic Alzheimer’s Disease Mouse Model: Focus on Antioxidant, Anti-Inflammatory, and Amyloidogenic Pathways
title_short Neuroprotective Effect of Artichoke-Based Nanoformulation in Sporadic Alzheimer’s Disease Mouse Model: Focus on Antioxidant, Anti-Inflammatory, and Amyloidogenic Pathways
title_sort neuroprotective effect of artichoke-based nanoformulation in sporadic alzheimer’s disease mouse model: focus on antioxidant, anti-inflammatory, and amyloidogenic pathways
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610800/
https://www.ncbi.nlm.nih.gov/pubmed/36297313
http://dx.doi.org/10.3390/ph15101202
work_keys_str_mv AT elnasharhebaas neuroprotectiveeffectofartichokebasednanoformulationinsporadicalzheimersdiseasemousemodelfocusonantioxidantantiinflammatoryandamyloidogenicpathways
AT abbashaidy neuroprotectiveeffectofartichokebasednanoformulationinsporadicalzheimersdiseasemousemodelfocusonantioxidantantiinflammatoryandamyloidogenicpathways
AT zewailmariam neuroprotectiveeffectofartichokebasednanoformulationinsporadicalzheimersdiseasemousemodelfocusonantioxidantantiinflammatoryandamyloidogenicpathways
AT noureldinmohamedh neuroprotectiveeffectofartichokebasednanoformulationinsporadicalzheimersdiseasemousemodelfocusonantioxidantantiinflammatoryandamyloidogenicpathways
AT alimaim neuroprotectiveeffectofartichokebasednanoformulationinsporadicalzheimersdiseasemousemodelfocusonantioxidantantiinflammatoryandamyloidogenicpathways
AT shamaamariumm neuroprotectiveeffectofartichokebasednanoformulationinsporadicalzheimersdiseasemousemodelfocusonantioxidantantiinflammatoryandamyloidogenicpathways
AT khattabmohameda neuroprotectiveeffectofartichokebasednanoformulationinsporadicalzheimersdiseasemousemodelfocusonantioxidantantiinflammatoryandamyloidogenicpathways
AT ibrahimnehal neuroprotectiveeffectofartichokebasednanoformulationinsporadicalzheimersdiseasemousemodelfocusonantioxidantantiinflammatoryandamyloidogenicpathways